These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35584986)

  • 1. COVID-19 Containment: Comparisons and Suggestions for Global Response.
    Cheng S; Zhao Y; Kaminga AC; Wang X; Zhang X; Xu H
    Inquiry; 2022; 59():469580221086142. PubMed ID: 35584986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. China's Fight Against COVID-19: What We Have Done and What We Should Do Next?
    Cheng S; Zhao Y; Kaminga AC; Zhang X; Xu H
    Front Public Health; 2022; 10():548056. PubMed ID: 35844877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
    Zhang P
    Front Public Health; 2021; 9():610824. PubMed ID: 33981659
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 emergencies around the globe: China's experience in controlling COVID-19 and lessons learned.
    Jin H; Lu L; Liu J; Cui M
    Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33320189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental management strategy in response to COVID-19 in China: Based on text mining of government open information.
    Kang A; Ren L; Hua C; Song H; Dong M; Fang Z; Zhu M
    Sci Total Environ; 2021 May; 769():145158. PubMed ID: 33485207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics.
    Kamel Boulos MN; Geraghty EM
    Int J Health Geogr; 2020 Mar; 19(1):8. PubMed ID: 32160889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global COVID-19: Warnings and suggestions based on experience of China.
    Ding Z; Xie L; Guan A; Huang D; Mao Z; Liang X
    J Glob Health; 2020 Jun; 10(1):011005. PubMed ID: 32509294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The governance of imported 2019-nCov infections: What can be learned from China's experience?
    Li H; He J; Chen J; Pan S; Feng J; Liu S
    Glob Health Res Policy; 2022 Mar; 7(1):8. PubMed ID: 35264241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 10. "A community system": A critical foundation for the epidemic prevention and control of SARS-CoV-2.
    Zhang X; Yang S
    Int J Health Plann Manage; 2020 Sep; 35(5):1246-1249. PubMed ID: 32677114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Trade of Masks and COVID-19 Pandemic Containment.
    Fan X; Li B; Xiu Y
    J Environ Public Health; 2022; 2022():2156950. PubMed ID: 35855816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. China's global engagement to fight the novel coronavirus pandemic.
    Song W
    Glob Health Res Policy; 2020; 5():44. PubMed ID: 33083550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of China's public health system response to COVID-19.
    Zhang P; Gao J
    J Glob Health; 2021 Jan; 11():05004. PubMed ID: 33643637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza.
    Li Q; Wang J; Lv H; Lu H
    Biosci Trends; 2021 Jul; 15(3):192-195. PubMed ID: 34176827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public Health Measures and the Control of COVID-19 in China.
    Cheng ZJ; Zhan Z; Xue M; Zheng P; Lyu J; Ma J; Zhang XD; Luo W; Huang H; Zhang Y; Wang H; Zhong N; Sun B
    Clin Rev Allergy Immunol; 2023 Feb; 64(1):1-16. PubMed ID: 34536214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policy disparities in response to the first wave of COVID-19 between China and Germany.
    Zhang Y; Shi L; Chen H; Wang X; Sun G
    Int J Equity Health; 2021 Mar; 20(1):86. PubMed ID: 33766049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Based on Contaminated Water and Human Health to Change of China's International Image Under Mainstream Media Reports During the COVID-19 Pandemic.
    Ji K; Zhou M; Yang Z; Zong H
    J Environ Public Health; 2022; 2022():7537056. PubMed ID: 36052353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of China's Hubei control strategy for COVID-19 epidemic: an observational study.
    Liu Y; Zheng F; Du Z; Li J; Gu J; Jiang M; Yoneoka D; Gilmour S; Hao Y
    BMC Infect Dis; 2021 Aug; 21(1):820. PubMed ID: 34399697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. China's local governments are combating COVID-19 with unprecedented responses - from a Wenzhou governance perspective.
    Gong F; Xiong Y; Xiao J; Lin L; Liu X; Wang D; Li X
    Front Med; 2020 Apr; 14(2):220-224. PubMed ID: 32166600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China.
    Zhou L; Wu Z; Li Z; Zhang Y; McGoogan JM; Li Q; Dong X; Ren R; Feng L; Qi X; Xi J; Cui Y; Tan W; Shi G; Wu G; Xu W; Wang X; Ma J; Su X; Feng Z; Gao GF
    Clin Infect Dis; 2021 Jan; 72(2):332-339. PubMed ID: 33501949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.